Results 271 to 280 of about 848,177 (365)

Spontaneous Intestinal Perforation in Extremely Premature Infants Exposed to Early Low‐Dose Hydrocortisone

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To assess the occurrence of spontaneous intestinal perforation (SIP) in < 28 weeks' gestational age (GA) infants exposed to early low‐dose hydrocortisone (ELH) to reduce the risk of bronchopulmonary dysplasia (BPD). Additionally, the risk of SIP was assessed in infants exposed to early concomitant treatment with ibuprofen for persistent ...
Gilles Cambonie   +5 more
wiley   +1 more source

Microaneurysm Counting as a Biomarker for the Hyperperfusion Stage of Nonproliferative Diabetic Retinopathy. [PDF]

open access: yesOphthalmol Ther
Mendes L   +10 more
europepmc   +1 more source

Raised serum apolipoprotein (a) in active diabetic retinopathy [PDF]

open access: bronze, 1993
Margherita Maioli   +6 more
openalex   +1 more source

Cerebral Oxygenation During Transition and Amplitude‐Integrated Electroencephalography Signals: An Ancillary Study to the COSGOD‐III Trial

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim The COSGOD III trial was designed to guide oxygen delivery by cerebral near infrared spectroscopy (NIRS) in preterm neonates during the immediate transition after birth and showed a non‐significant increase of 4.3% in survival without cerebral injury compared to the control group.
Christina Schreiner   +9 more
wiley   +1 more source

Development and Content of Core Outcome Sets in Neonatology—A Scoping Review

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To identify subgroups of neonates for whom core outcome sets (COS) have been developed, the outcomes that were included and the methods used in their formulation. Methods We performed a scoping review and searched databases in April 2025 for published COS.
Ilari Kuitunen   +3 more
wiley   +1 more source

Evaluating lipid-lowering drug targets for full-course diabetic retinopathy. [PDF]

open access: yesBr J Ophthalmol
Cao J   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy